TY - JOUR
T1 - Probable early-onset group B streptococcal neonatal sepsis: A serious clinical condition related to intrauterine infection
AU - Carbonell-Estrany, X.
AU - Figueras-Aloy, J.
AU - Salcedo-Abizanda, S.
AU - De La Rosa-Fraile, M.
AU - Salcedo, S.
AU - López Sastre, J.
AU - Coto Cotallo, G. D.
AU - Fernández Colomer, B.
AU - González, T.
AU - Reparaz Vidal, R.
AU - Fidalgo Álvarez, I.
AU - Alvaro Iglesias, E.
AU - Aragón García, M. P.
AU - González Armengod, C.
AU - Pedraz García, C.
AU - Urbón Artero, A.
AU - Aparicio Lozano, P.
AU - Cotero Lavín, A.
AU - Paisán Grisolía, L.
AU - De Alba Romero, C.
AU - Sánchez Luna, M.
AU - Moro Serrano, M.
AU - Botet, F.
AU - Krauel Vidal, X.
AU - Iriondo Sanz, M.
AU - Porta, R.
AU - Roqués Serradilla, V.
AU - Ortiz Tardío, J.
AU - García Del Río, M.
AU - Guzmán Cabañas, J.
AU - Zamarriego, C.
AU - Rosso González, M. L.
AU - García García, M. J.
AU - Doménech Martínez, E.
PY - 2008/3/1
Y1 - 2008/3/1
N2 - Background: The estimated incidence of true early-onset group B streptococcal (GBS) neonatal infection is based on positive GBS blood or cerebrospinal fluid (CSF) culture results, but the real burden of disease is underestimated owing to the high incidence of culture-negative sepsis possibly because of antibiotic administration to the mother. Objective: To examine the rate of probable early-onset GBS neonatal sepsis and to assess its impact on total GBS neonatal disease. Design: A multicentre longitudinal prospective surveillance of 107 021 deliveries. Results: The rates of culture-proven and probable early-onset GBS sepsis were 0.39 and 0.47 per 1000 live births, respectively. Of great concern was the finding of three deaths related to the infection in the group with probable early-onset GBS sepsis. Conclusions: The use of chemoprophylaxis in GBS-colonised pregnant women, especially when it is incomplete, may not be sufficient to prevent clinical neonatal infection, but may inhibit the growth of GBS in blood and CSF cultures. In assessing the effectiveness of GBS prophylaxis, it is advisable to consider the incidence of culture-positive and probable culture-negative GBS neonatal infection.
AB - Background: The estimated incidence of true early-onset group B streptococcal (GBS) neonatal infection is based on positive GBS blood or cerebrospinal fluid (CSF) culture results, but the real burden of disease is underestimated owing to the high incidence of culture-negative sepsis possibly because of antibiotic administration to the mother. Objective: To examine the rate of probable early-onset GBS neonatal sepsis and to assess its impact on total GBS neonatal disease. Design: A multicentre longitudinal prospective surveillance of 107 021 deliveries. Results: The rates of culture-proven and probable early-onset GBS sepsis were 0.39 and 0.47 per 1000 live births, respectively. Of great concern was the finding of three deaths related to the infection in the group with probable early-onset GBS sepsis. Conclusions: The use of chemoprophylaxis in GBS-colonised pregnant women, especially when it is incomplete, may not be sufficient to prevent clinical neonatal infection, but may inhibit the growth of GBS in blood and CSF cultures. In assessing the effectiveness of GBS prophylaxis, it is advisable to consider the incidence of culture-positive and probable culture-negative GBS neonatal infection.
U2 - 10.1136/adc.2007.119958
DO - 10.1136/adc.2007.119958
M3 - Article
SN - 1359-2998
VL - 93
JO - Archives of Disease in Childhood: Fetal and Neonatal Edition
JF - Archives of Disease in Childhood: Fetal and Neonatal Edition
IS - 2
ER -